XT
DRMA icon

XTX Topco’s Dermata Therapeutics DRMA Stock Holding History

XTX Topco’s Portfolio DRMA Stock Details DRMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.1K Buy
+14,787
New +$18.6K ﹤0.01% 3915
2025
Q3 		– Sell
-3,449
Closed -$20.2K – 2720
2025
Q2 		$20.2K Buy
+3,449
New +$26.4K ﹤0.01% 2162

Other funds holding DRMA

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
AA
Advisory Alpha Holland, Michigan $4.08B AUM 20.62% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
MA
MCF Advisors Covington, Kentucky $2.8B AUM 19.11% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

XTX Topco's DRMA Position: Q2 2026 in Review

XTX Topco opened a new position in Dermata Therapeutics (DRMA) in Q2 2026: 14,787 shares worth $19.1K. The stake represents ﹤0.01% of the portfolio and ranks #3915 among its holdings. This is a return to the name: XTX Topco previously reported a position in DRMA as recently as Q2 2025.

XTX Topco first reported a position in DRMA in Q2 2025 and has held it in 2 quarters since. The position peaked at $20.2K in Q2 2025. 13 funds tracked by Wall St. Rank hold DRMA as of Q2 2026.

  • XTX Topco held 14,787 shares of Dermata Therapeutics worth $19.1K as of Q2 2026.
  • Dermata Therapeutics was a new XTX Topco position in Q2 2026.
  • Dermata Therapeutics made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3915 holding.
  • XTX Topco first reported a position in Dermata Therapeutics in Q2 2025 and has held it in 2 quarters since.
  • XTX Topco's Dermata Therapeutics position peaked at $20.2K in Q2 2025.
  • 13 funds tracked by Wall St. Rank held Dermata Therapeutics as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.